Dermapharm Holding Future Growth

Future criteria checks 1/6

Dermapharm Holding is forecast to grow earnings and revenue by 18.1% and 4.1% per annum respectively. EPS is expected to grow by 18.1% per annum. Return on equity is forecast to be 18.6% in 3 years.

Key information

18.1%

Earnings growth rate

18.1%

EPS growth rate

Pharmaceuticals earnings growth21.5%
Revenue growth rate4.1%
Future return on equity18.6%
Analyst coverage

Low

Last updated15 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:DMP - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,2811401682284
12/31/20251,2211301562145
12/31/20241,1711081632095
9/30/20241,17491157197N/A
6/30/20241,14783146187N/A
3/31/20241,12957137179N/A
12/31/20231,15162178219N/A
9/30/20231,17295240279N/A
6/30/20231,151123267304N/A
3/31/20231,128146287323N/A
12/31/20221,041134250289N/A
9/30/20221,024176222269N/A
6/30/20221,004185191249N/A
3/31/2022980211190252N/A
12/31/2021960210189250N/A
9/30/2021902162153209N/A
6/30/2021858123115164N/A
3/31/20218289596139N/A
12/31/20208088690131N/A
9/30/20207758060104N/A
6/30/2020760775897N/A
3/31/20207438569114N/A
12/31/20197147754101N/A
9/30/2019674735190N/A
6/30/20196397770109N/A
3/31/20196117384115N/A
12/31/201858475133159N/A
9/30/201855875143165N/A
6/30/201852576N/A137N/A
3/31/201849879N/A120N/A
12/31/201748078N/A87N/A
9/30/201748684N/A84N/A
12/31/201645577N/A77N/A
12/31/201539613N/A40N/A
12/31/20144020N/A54N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DMP's forecast earnings growth (18.1% per year) is above the savings rate (1%).

Earnings vs Market: DMP's earnings (18.1% per year) are forecast to grow slower than the German market (21.1% per year).

High Growth Earnings: DMP's earnings are forecast to grow, but not significantly.

Revenue vs Market: DMP's revenue (4.1% per year) is forecast to grow slower than the German market (5.7% per year).

High Growth Revenue: DMP's revenue (4.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: DMP's Return on Equity is forecast to be low in 3 years time (18.6%).


Discover growth companies